BERWYN, Pa.–(BUSINESS WIRE)–#pharma—Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral indications, today announced that Mr. Anthony P. Mack, Chairman and Chief Executive Officer, will present and host one-on-one meetings with investors at the Sidoti Read the full article...
The post Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference May 10-11, 2023 first appeared on MJNews Network.
http://dlvr.it/SnWxV4
No comments:
Post a Comment